Filing Details
- Accession Number:
- 0001567619-21-011579
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-02 21:02:06
- Reporting Period:
- 2021-06-01
- Accepted Time:
- 2021-06-02 21:02:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1704292 | Zai Lab Ltd | ZLAB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1835836 | Chul Ki William Cho | C/O Zai Lab Limited 4560 Jinke Road, Bldg 1, 4Th Floor Pudong, Shanghai F4 201210 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2021-06-01 | 8,584 | $180.12 | 51,416 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2021-06-02 | 1,416 | $180.69 | 50,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 19, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.